Health & Medicine
- Neuroscience
Blood exerts a powerful influence on the brain
Instead of just responding to the energy needs of neurons, the blood can have a direct and powerful influence on the brain.
- Health & Medicine
Daily drug shown effective in preventing HIV infections
After a history of controversy, preexposure prophylaxis has been demonstrated to work for HIV prevention.
- Health & Medicine
Eating meat officially raises cancer risk
Eating processed meats like bacon, ham and sausage causes cancer, says the World Health Organization.
- Neuroscience
Signs of Alzheimer’s seen in young brain’s GPS cells
Signs of Alzheimer’s can show up in the brain’s compass decades before symptoms strike.
- Health & Medicine
Hollywood-made science documentary series comes to TV
Breakthrough series gives a closer look at scientists at work.
- Neuroscience
Signs of Huntington’s show up in the brain in childhood
Hints of Huntington’s disease show up in the brain long before symptoms do.
- Chemistry
Nanoparticles in foods raise safety questions
As scientists cook up ways to improve palatability and even make foods healthier, some are considering the potential health risks of tiny additives.
- Health & Medicine
First known case of sexually transmitted Ebola reported
A Liberian woman contracted Ebola in March by having sex with a survivor of the viral disease, researchers report.
- Neuroscience
Adolescent brains open to change
Adolescent brains are still changing, a malleability that renders them particularly sensitive to the outside world.
- Genetics
Microbes may reveal colon cancer mutations
Certain microbial mixes are associated with particular DNA mutations in colon cancer, a new study suggests.
- Health & Medicine
Cancer drug’s effectiveness overinflated in animal studies
Claims about the cancer drug sunitinib are overblown because of poorly designed studies and negative results that were never published, a new analysis suggests.
- Health & Medicine
Cancer drug’s effectiveness overinflated in animal studies
Claims about the cancer drug sunitinib are overblown because of poorly designed studies and negative results that were never published, a new analysis suggests.
